[1] Barsom SH, Dillaway HE, Koch PB, et al. The menstrual cycle and adolescent health [J]. Ann NY Acad Sci, 2008, 1135:52-57. [2] Yildiz BO, Bolour S, Woods K, et al. Visually scoring hirsutism [J]. Hum Reprod Update, 2010, 16(1): 51-64. [3] Zhao X, Ni R, Li L,et al. Defining hirsutism in Chinese women: a cross-sectional study [J]. Fertil Steril, 2011, 96(3): 792-796. [4] Olutunmbi Y, Paley K, English JC 3rd. Adolescent female acne: etiology and management[J]. J Pediatr Adolesc Gynecol, 2008, 21(4): 171-176. [5] Balen AH,Conmwy GS,Homburg R,et al. Polycystic ovary syndrome [M]. United Kingdom:Taylor & Francis Press,2005:59-64. [6] 陈亚肖,杨冬梓,李琳,等. 青春期和成年多囊卵巢综合征患者卵巢体积和卵泡数目的比较[J].中国临床医学影像杂志,2007,18(5):330-332. [7] 徐晶晶,赵赟,林金芳. 青春期多囊卵巢综合征患者胰岛素抵抗及糖代谢异常的分析[J]. 中华内分泌代谢杂志, 2010, 26(5): 355-358. [8] 徐丽爽,张艳芳,张慧英,等. 不同分组多囊卵巢综合征患者糖代谢特征分析[J]. 现代妇产科进展, 2010, 19(5): 333-335. [9] 倪仁敏,钟俊敏,陈晓莉,等. 多囊卵巢综合征患者糖代谢异常发生率及其特点[J]. 中华糖尿病杂志, 2009, 1(6): 417-421. [10] Essah PA, Wickham EP, Nestler JE. The metabolic syndrome in polycystic ovary syndrome[J]. Clin Obstet Gynecol, 2007, 50(1): 205-225. [11] Azziz R, Carmina E, Dewailly D, et al.Task Force on the Phenotype of the Polycystic Ovary Syndrome of The Androgen Excess and PCOS Society. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report[J]. Fertil Steril, 2009, 91(2): 456-488. [12] American Diabetes Association. Type 2 diabetes in children and adolescents[J]. Diabetes Care, 2000, 23(3): 381-389. [13] Legro RS,Kunselman AR,Dodson WC,et al.Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome:a prospective,controlled study in 254 affected women[J].J Clin Endocrinol Metab,1999,84(1):165-169. [14] Weerakiet S, Srisombut C, Bunnag P, et a1.Prevalence of type 2 diabetes mellitus and impaired glucose tolerance in Asian women with polycystic ovary syndrome[J].Int J Gynaecol Obstet, 2001, 75(2):177-184. [15] Huang J, Ni R, Chen X, et al. Metabolic abnormalities in adolescents with polycystic ovary syndrome in south China[J]. Reprod Biol Endocrinol, 2010, 8: 142. [16] Hart R, Doherty DA, Mori T, et al. Extent of metabolic risk in adolescent girls with features of polycystic ovary syndrome[J]. Fertil Steril, 2011, 95(7): 2347-53, 2353. e1 [17] Sultan C, Paris F. Clinical expression of polycystic ovary syndrome in adolescent girls[J]. Fertil Steril, 2006, 86(suppl 1):S6. [18] Carmina E, Oberfield SE, Lobo RA. The diagnosis of polycystic ovary syndrome in adolescents[J]. Am J Obstet Gynecol, 2010, 203(3):201.e1-e5. [19] 赵赟,徐晶晶,朱铭伟,等. 青春期多囊卵巢综合征患者临床、内分泌代谢紊乱特征及诊断初探[J]. 中华医学杂志, 2010, 90(25): 1729-1734. [20] Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group[J].Fertil Steril,2012, 97(1):28-38.e25. [21] Chen X, Ni R, Mo Y, et al. Appropriate BMI levels for PCOS patients in Southern China[J]. Hum Reprod, 2010, 25(5): 1295-1302. [22] Ibanez L, de Zegher F.Low-dose flutamide metformin therapy for hyperinsulinemic hyperandrogenism in nonobese adolescents and women [J]. Fertil Steril, 2006, 86(Suppl 1): S24-S25. |